Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00475761 · ClinicalTrials.gov registry record

Breast Mammogram and Tissue Study

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
466
Enrollment target

NCT00475761: Completed study, sponsored by National Cancer Institute (NCI).

NCT00475761 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 466 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00475761 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
466 participants
Enrollment target

Study Summary

Background: Women whose mammograms show a lot of dense areas are more likely to develop breast cancer and to have cancers that are missed by mammograms. It is unclear why some factors lead to having dense breasts and why having dense breasts increases the risk of developing breast cancer. Objectives: To determine why some women s breasts look dense on mammograms. To determine what types of cells and tissues make up dense areas of breasts and why these tissues may be more likely to become cancerous. Eligibility: Women between 40 and 65 years of age who have not had breast cancer or received medicines or radiation for any type of cancer and who are scheduled to undergo a breast biopsy. Design: This study is conducted at the University of Vermont, in collaboration with the NCI. Participants undergo the following: * Review of their medical records collected over the last 2 years by the Vermont Mammography Registry. * Participation in a short telephone interview. * Height and weight measurement. * Testing of biopsy tissue collected for diagnosis or treatment. * Future contacts regarding health status for up to 10 years, including review of additional mammograms, removed tissues, questionnaires and medical records collected by the Vermont Mammography Registry during the 10-year study. Participants may also undergo the following optional procedures: * Provide a mouthwash sample for genetic testing. * Provide a blood sample to test for markers of dense mammograms or breast cancer.

Trial Details

FieldValue
Enrollment Target 466 participants
Start Date 2007-05-11

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT00475761

The ClinicalTrials.gov registry entry for NCT00475761 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 466 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00475761 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00475761 about?

NCT00475761 is a clinical study titled "Breast Mammogram and Tissue Study". Background: Women whose mammograms show a lot of dense areas are more likely to develop breast cancer and to have cancers that are missed by mammograms. It is unclear why some factors lead to having dense breasts and why having dense breasts increases the risk of developing breast cancer. Objecti...

What is the current status of trial NCT00475761?

This trial is currently completed. The enrollment target is 466 participants. The study started on 2007-05-11.

Who is sponsoring clinical trial NCT00475761?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.